Cytoplasmic PKM2 interacts with CD44 (a cell surface biomarker of cancer stem cells) and boosts glucose uptake and PPP flux, which maintains cellular redox homeostasis and protects cancer cells against anticancer drugs (Tamada et al., 2012). This evidence concerns the gene CD44 and cancer.